Helga Westerlind1, Leszek Stawiarz2, Katharina Fink3, Jan Hillert4, Ali Manouchehrinia2. 1. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. 2. Department of Clinical Neuroscience (CNS), Karolinska Institutet, Stockholm, Sweden. 3. Department of Clinical Neuroscience (CNS), Karolinska Institutet, Stockholm, Sweden/Department of Neurology, Karolinska University Hospital, Huddinge, Sweden. 4. Department of Clinical Neuroscience (CNS), Karolinska Institutet, Stockholm, Sweden/Department of Neurology, Karolinska University Hospital, Huddinge, Sweden Jan.Hillert@ki.se.
Abstract
BACKGROUND: Several reports indicate changes to prevalence, incidence, female-to-male ratio in multiple sclerosis. Diagnostic criteria, course definitions and clinical management of the disease have also undergone change during the recent decades. OBJECTIVE: To investigate temporal trends in the diagnosis of primary progressive multiple sclerosis (PPMS) in Sweden. METHODS: Through the Swedish MS registry we investigated the proportion of PPMS diagnosis in birth, diagnosis and age period cohorts using Poisson regression. RESULTS: A total of 16,915 patients were categorised into six birth-cohorts from 1946 to 1975 and seven date-of-diagnosis-cohorts from 1980 to 2014. We observed a decrease in the uncorrected analysis of diagnosis of PPMS from 19.2% to 2.2% and an average decrease of 23% (p < 0.001) per 5-year birth-cohort in the adjusted analysis. An average 21% (p < 0.001) decrease per diagnosis-cohort was seen. In the age-specific diagnosis period cohorts the same decreasing trend of PPMS diagnosis was observed in almost all groups. CONCLUSION: The diagnosis of PPMS has significantly decreased in Sweden specifically after introduction of disease-modifying treatments. Such decrease can have severe impacts on the future research on PPMS. Our data also suggest that the current trend to emphasise presence or absence of inflammatory activity is already reflected in clinical practice.
BACKGROUND: Several reports indicate changes to prevalence, incidence, female-to-male ratio in multiple sclerosis. Diagnostic criteria, course definitions and clinical management of the disease have also undergone change during the recent decades. OBJECTIVE: To investigate temporal trends in the diagnosis of primary progressive multiple sclerosis (PPMS) in Sweden. METHODS: Through the Swedish MS registry we investigated the proportion of PPMS diagnosis in birth, diagnosis and age period cohorts using Poisson regression. RESULTS: A total of 16,915 patients were categorised into six birth-cohorts from 1946 to 1975 and seven date-of-diagnosis-cohorts from 1980 to 2014. We observed a decrease in the uncorrected analysis of diagnosis of PPMS from 19.2% to 2.2% and an average decrease of 23% (p < 0.001) per 5-year birth-cohort in the adjusted analysis. An average 21% (p < 0.001) decrease per diagnosis-cohort was seen. In the age-specific diagnosis period cohorts the same decreasing trend of PPMS diagnosis was observed in almost all groups. CONCLUSION: The diagnosis of PPMS has significantly decreased in Sweden specifically after introduction of disease-modifying treatments. Such decrease can have severe impacts on the future research on PPMS. Our data also suggest that the current trend to emphasise presence or absence of inflammatory activity is already reflected in clinical practice.
Authors: Andrius Kavaliunas; Ali Manouchehrinia; Virginija Danylaite Karrenbauer; Hanna Gyllensten; Anna Glaser; Kristina Alexanderson; Jan Hillert Journal: PLoS One Date: 2017-01-12 Impact factor: 3.240
Authors: Elisabeth Anens; Lena Zetterberg; Charlotte Urell; Margareta Emtner; Karin Hellström Journal: BMC Neurol Date: 2017-12-01 Impact factor: 2.474